Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Winters, MA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 40 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Shulman, NS; Machekano, RA; Shafer, RW; Winters, MA; Zolopa, AR; Liou, SH; Hughes, M; Katzenstein, DA
      Genotypic correlates of a virologic response to stavudine after zidovudinemonotherapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Winters, MA; Merigan, TC
      Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nucleoside analogs

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    3. Kim, EY; Winters, MA; Kagan, RM; Merigan, TC
      Functional correlates of insertion mutations in the protease gene of humanimmunodeficiency virus type 1 isolates from patients

      JOURNAL OF VIROLOGY
    4. Winters, MA; Baxter, JD; Mayers, DL; Wentworth, DN; Hoover, ML; Neaton, JD; Merigan, TC
      Frequency of antiretroviral drug resistance mutations in HIV-1 strains from patients failing triple drug regimens

      ANTIVIRAL THERAPY
    5. Baxter, JD; Mayers, DL; Wentworth, DN; Neaton, JD; Hoover, ML; Winters, MA; Mannheimer, SB; Thompson, MA; Abrams, DI; Brizz, BJ; Ioannidis, JPA; Merigan, TC
      A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy

      AIDS
    6. Shafer, RW; Warford, A; Winters, MA; Gonzales, MJ
      Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals

      JOURNAL OF VIROLOGICAL METHODS
    7. Winters, MA; Coolley, KL; Cheng, P; Girard, YA; Hamdan, H; Kovari, LC; Merigan, TC
      Genotypic, phenotypic, and modeling studies of a deletion in the beta 3-beta 4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors

      JOURNAL OF VIROLOGY
    8. Schapiro, JM; Winters, MA; Lawrence, J; Merigan, TC
      Clinical cross-resistance between the HIV-1 protease inhibitors saquinavirand indinavir and correlations with genotypic mutations

      AIDS
    9. Schapiro, JM; Lawrence, J; Speck, R; Winters, MA; Efron, B; Coombs, RW; Collier, AC; Merigan, TC
      Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS Clinical Trials Group 229

      JOURNAL OF INFECTIOUS DISEASES
    10. Gray, CM; Lawrence, J; Schapiro, JM; Altman, JD; Winters, MA; Crompton, M; Loi, M; Kundu, SK; Davis, MM; Merigan, TC
      Frequency of class I HLA-restricted anti-HIV CD8(+) T cells in individualsreceiving highly active antiretroviral therapy (HAART)

      JOURNAL OF IMMUNOLOGY
    11. Winters, MA; Frankel, DZ; Debenedetti, PG; Carey, J; Devaney, M; Przybycien, TM
      Protein purification with vapor-phase carbon dioxide

      BIOTECHNOLOGY AND BIOENGINEERING
    12. GRAY CM; SCHAPIRO JM; WINTERS MA; MERIGAN TC
      CHANGES IN CD4(-CELL SUBSETS IN RESPONSE TO HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY IN HIV TYPE 1-INFECTED PATIENTS WITH PRIOR PROTEASE INHIBITOR EXPERIENCE() AND CD8(+) T)

      AIDS research and human retroviruses
    13. WINTERS MA; SCHAPIRO JM; LAWRENCE J; MERIGAN TC
      HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE GENOTYPES AND IN-VITRO PROTEASE INHIBITOR SUSCEPTIBILITIES OF ISOLATES FROM INDIVIDUALS WHO WERE SWITCHED TO OTHER PROTEASE INHIBITORS AFTER LONG-TERM SAQUINAVIR TREATMENT

      Journal of virology
    14. SCHAPIRO JM; WINTERS MA; VIERRA M; CRAWFORD S; MERIGAN TC
      LYMPH-NODE HUMAN-IMMUNODEFICIENCY-VIRUS RNA LEVELS AND RESISTANCE MUTATIONS IN PATIENTS RECEIVING HIGH-DOSE SAQUINAVIR

      The Journal of infectious diseases
    15. WINTERS MA; COOLLEY KL; GIRARD YA; LEVEE DJ; HAMDAN H; SHAFER RW; KATZENSTEIN DA; MERIGAN TC
      A 6-BASEPAIR INSERT IN THE REVERSE-TRANSCRIPTASE GENE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CONFERS RESISTANCE TO MULTIPLE NUCLEOSIDE INHIBITORS

      The Journal of clinical investigation
    16. SHAFER RW; WINTERS MA; PALMER S; MERIGAN TC
      MULTIPLE CONCURRENT REVERSE-TRANSCRIPTASE AND PROTEASE MUTATIONS AND MULTIDRUG-RESISTANCE OF HIV-1 ISOLATES FROM HEAVILY TREATED PATIENTS

      Annals of internal medicine
    17. Shafer, RW; Winters, MA; Palmer, S; Merigan, TC
      Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients (vol 128, pg 906, 1998)

      ANNALS OF INTERNAL MEDICINE
    18. WINTERS MA; DEBENEDETTI PG; CAREY J; SPARKS HG; SANE SU; PRZYBYCIEN TM
      LONG-TERM AND HIGH-TEMPERATURE STORAGE OF SUPERCRITICALLY-PROCESSED MICROPARTICULATE PROTEIN POWDERS

      Pharmaceutical research
    19. SHAFER RW; LEVEE DJ; WINTERS MA; RICHMOND KL; HUANG D; MERIGAN TC
      COMPARISON OF QIAAMP HCV KIT SPIN COLUMNS, SILICA BEADS, AND PHENOL-CHLOROFORM FOR RECOVERING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA FROM PLASMA

      Journal of clinical microbiology
    20. WINTERS MA; SHAFER RW; JELLINGER RA; MAMTORA G; GINGERAS T; MERIGAN TC
      HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE GENOTYPE AND DRUG SUSCEPTIBILITY CHANGES IN INFECTED INDIVIDUALS RECEIVING DIDEOXYINOSINE MONOTHERAPY FOR 1 TO 2 YEARS

      Antimicrobial agents and chemotherapy
    21. MERIGAN TC; HIRSCH RL; FISHER AC; MEYERSON LA; GOLDSTEIN G; WINTERS MA
      THE PROGNOSTIC-SIGNIFICANCE OF SERUM VIRAL LOAD, CODON-215 REVERSE-TRANSCRIPTASE MUTATION AND CD4-CELLS ON PROGRESSION OF HIV DISEASE IN A DOUBLE-BLIND-STUDY OF THYMOPENTIN( T)

      AIDS
    22. WHITTAKER L; SCHAPIRO JM; CRAIG JC; WINTERS MA; TOMLINSON PW; SHELDON JG; MOFFATT AR; JACOBSEN H; DUNCAN IB; GILBERT S; CRAWFORD S; MERIGAN TC
      AN ASSESSMENT OF PHENOTYPIC AND GENOTYPIC CORESISTANCE TO INHIBITORS OF HIV PROTEINASE FOLLOWING THERAPY WITH HIGH-DOSE SAQUINAVIR

      AIDS
    23. VANHOVE GF; SCHAPIRO JM; WINTERS MA; MERIGAN TC; BLASCHKE TF
      PATIENT COMPLIANCE AND DRUG FAILURE IN PROTEASE INHIBITOR MONOTHERAPY

      JAMA, the journal of the American Medical Association
    24. SHAFER RW; WINTERS MA; MAYERS DL; JAPOUR AJ; KURITZKES DR; WEISLOW OS; WHITE F; ERICE A; SANNERUD KJ; IVERSEN A; PENA F; DIMITROV D; FRENKEL LM; REICHELDERFER PS
      INTERLABORATORY COMPARISON OF SEQUENCE-SPECIFIC PCR AND LIGASE DETECTION REACTION TO DETECT A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DRUG-RESISTANCE MUTATION

      Journal of clinical microbiology
    25. SHAFER RW; WINTERS MA; IVERSEN AKN; MERIGAN TC
      GENOTYPIC AND PHENOTYPIC CHANGES DURING CULTURE OF A MULTINUCLEOSIDE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAIN IN THE PRESENCE AND ABSENCE OF ADDITIONAL REVERSE-TRANSCRIPTASE INHIBITORS

      Antimicrobial agents and chemotherapy
    26. WINTERS MA; DEBENEDETTI PG; CONDO PD; RADOSZ M; SCHMIDT HW
      EFFECTS OF COMPRESSED CARBON-DIOXIDE ON THE PHASE-EQUILIBRIUM AND MOLECULAR ORDER OF A LYOTROPIC POLYAMIDE SOLUTION

      Macromolecules
    27. IVERSEN AKN; SHAFER RW; WEHRLY K; WINTERS MA; MULLINS JI; CHESEBRO B; MERIGAN TC
      MULTIDRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS RESULTING FROM COMBINATION ANTIRETROVIRAL THERAPY

      Journal of virology
    28. SHAFER RW; WINTERS MA; JELLINGER RM; MERIGAN TC
      ZIDOVUDINE RESISTANCE REVERSE-TRANSCRIPTASE MUTATIONS DURING DIDANOSINE MONOTHERAPY

      The Journal of infectious diseases
    29. RAMACHANDRAN R; KATZENSTEIN DA; WINTERS MA; KUNDU SK; MERIGAN TC
      POLYETHYLENE GLYCOL-MODIFIED INTERLEUKIN-2 AND THYMOSIN ALPHA(1) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION

      The Journal of infectious diseases
    30. KOZAL MJ; SHAFER RW; WINTERS MA; KATZENSTEIN DA; HALPERN J; MERIGAN TC
      THE ASSOCIATION BETWEEN HIV PHENOTYPE, VIRUS BURDEN, CODON-215 MUTATION AND CD4 CELL DECLINE - REPLY

      Journal of acquired immune deficiency syndromes and human retrovirology
    31. SHAFER RW; IVERSEN AKN; WINTERS MA; AGUINIGA E; KATZENSTEIN DA; MERIGAN TC
      DRUG-RESISTANCE AND HETEROGENEOUS LONG-TERM VIROLOGICAL RESPONSES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED SUBJECTS TO ZIDOVUDINE AND DIDANOSINE COMBINATION THERAPY

      The Journal of infectious diseases
    32. KOZAL MJ; SHAFER RW; WINTERS MA; KATZENSTEIN DA; MERIGAN TC
      CLARIFICATION OF A METHOD TO REVERSE TRANSCRIBE HUMAN-IMMUNODEFICIENCY-VIRUS RNA

      The Journal of infectious diseases
    33. KOZAL MJ; SHAFER RW; WINTERS MA; KATZENSTEIN DA; AGUINIGA E; HALPERN J; MERIGAN TC
      HIV-1 SYNCYTIUM-INDUCING PHENOTYPE, VIRUS BURDEN CODON-215 REVERSE-TRANSCRIPTASE MUTATION AND CD4 CELL DECLINE IN ZIDOVUDINE-TREATED PATIENTS

      Journal of acquired immune deficiency syndromes
    34. KROODSMA KL; KOZAL MJ; HAMED KA; WINTERS MA; MERIGAN TC
      DETECTION OF DRUG-RESISTANCE MUTATIONS IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) POL GENE - DIFFERENCES IN SEMEN AND BLOOD HIV-1 RNA AND PROVIRAL DNA

      The Journal of infectious diseases
    35. LIN HJ; MYERS LE; YENLIEBERMAN B; HOLLINGER FB; HENRARD D; HOOPER CJ; KOKKA R; KWOK S; RASHEED S; VAHEY M; WINTERS MA; MCQUAY LJ; NARA PL; REICHELDERFER P; COOMBS RW; JACKSON JB
      MULTICENTER EVALUATION OF QUANTIFICATION METHODS FOR PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA

      The Journal of infectious diseases
    36. SHAFER RW; KOZAL MJ; WINTERS MA; IVERSEN AKN; KATZENSTEIN DA; RAGNI MV; MEYER WA; GUPTA P; RASHEED S; COOMBS R; KATZMAN M; FISCUS S; MERIGAN TC
      COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE SELECTS FOR DRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS WITH UNIQUE PATTERNS OF POL GENE-MUTATIONS

      The Journal of infectious diseases
    37. KOZAL MJ; KROODSMA K; WINTERS MA; SHAFER RW; EFRON B; KATZENSTEIN DA; MERIGAN TC
      DIDANOSINE RESISTANCE IN HIV-INFECTED PATIENTS SWITCHED FROM ZIDOVUDINE TO DIDANOSINE MONOTHERAPY

      Annals of internal medicine
    38. WINTERS MA; MERIGAN TC
      CONTINUOUS PRESENCE OF CD4-PE40 IS REQUIRED FOR ANTIVIRAL ACTIVITY AGAINST SINGLE-PASSAGE HIV ISOLATES AND INFECTED PERIPHERAL-BLOOD MONONUCLEAR-CELLS

      AIDS research and human retroviruses
    39. WINTERS MA; TAN LB; KATZENSTEIN DA; MERIGAN TC
      BIOLOGICAL VARIATION AND QUALITY-CONTROL OF PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA QUANTITATION BY REVERSE-TRANSCRIPTASE POLYMERASECHAIN-REACTION

      Journal of clinical microbiology
    40. WINTERS MA; STOKES PSN; ZUNIGA PO; SCHLOTTENMIER DJ
      REAL-TIME PERFORMANCE MONITORING OF FOULING AND UNDER-DEPOSIT CORROSION IN COOLING WATER-SYSTEMS

      Corrosion science


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 13:14:45